Serum Institute of India
Overview
Serum Institute of India Pvt. Ltd. (SIIPL) is an Indian biotechnology and pharmaceuticals company. It is the world's largest vaccine manufacturer by number of doses produced globally. The company manufactures highly specialized life-saving biologics like vaccines using cutting-edge genetic and cell-based technologies, among others.
About Us
Founded in 1966 by Dr. Cyrus Poonawalla, Serum Institute of India Pvt. Ltd. was established to address the critical shortage and high cost of imported life-saving immuno-biologics in India, aiming to reduce the nation's reliance on foreign vaccines. The company has since become the world’s largest vaccine manufacturer by volume, producing and selling over 1.5 billion doses globally. Its extensive portfolio includes vaccines against Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella. It is estimated that approximately 65% of children worldwide receive at least one vaccine manufactured by Serum Institute. This highlights the company's significant contribution to global health and its commitment to providing affordable and accessible vaccines to vulnerable populations worldwide. Serum Institute continues to innovate and expand its production capabilities to meet the ever-growing demand for life-saving vaccines, solidifying its position as a leader in the global vaccine industry. The company's mission remains focused on ensuring equitable access to vaccines, particularly in developing countries, and contributing to the eradication of preventable diseases.
Vision
To be a global leader in the development, manufacturing, and supply of vaccines and biologics, contributing to a healthier world.
Mission
To provide high-quality, affordable vaccines and biologics to protect global health.
Headquarters
Pune
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities